Loading...
Loading...
- Emerson Electric Co. EMR reported fourth-quarter net sales growth of 8.5% year-over-year to $4.95 billion, missing the consensus of $5.09 billion. Underlying sales were up 7%.
- Adjusted EPS improved to $1.21 from $1.10 in 4Q20, beating the consensus of $1.18.
- Sales by segments: Measurement & Analytical Instrumentation $860 million (+3.9% Y/Y), Valves, Actuators & Regulators $961 million (-1.9% Y/Y), Industrial Solutions $610 million (+12.6% Y/Y), Systems & Software $747 million (+14.1% Y/Y), Climate Technologies $1.29 billion (+16% Y/Y) and Tools & Home Products $486 million (+9.5% Y/Y).
- North America continued its strong recovery for the quarter despite supply chain challenges, with the Americas up 16%, while Europe was down 2%. Asia, Middle East & Africa was down 3%, with China up 10%.
- Pretax Margin of 16.7% down 10 bps and Adjusted EBIT Margin was 19%, down 30 bps.
- Emerson Electric's Operating Cash Flow was $3.6 billion (+16% Y/Y); Free Cash Flow was $3 billion, up 18%.
- 1Q22 Outlook: Emerson Electric expects net sales growth of 7% - 9%, with underlying sales growth of 7% - 9%. It expects an Adjusted EPS of $0.98 - $1.02 versus the consensus of $0.94.
- FY22 Outlook: Emerson Electric expects net sales growth of 5%-7%, with underlying sales growth of 6%-8%. It expects an Adjusted EPS of $4.82 - $4.97 versus the consensus of $4.57.
- Price Action: EMR shares are lower by 1.15% at $99 during the premarket session on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in